Elevation of serotonin, being associated with depression, platelet activation and increased cardiovascular risk (Williams, 2012), was found in myocardial tissue, accompanied by increased expression of 5HT2B (one of serotonin receptors), which suggests serotonin system to be involved in remodeling processes during development of CHF. Here, HTR2B is linked to depressive symptom measurement.